Summary:
Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-16 to 21-28 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq] (PubMed Links)
|
| Domains and Motifs:
TM: Transmembrane domain AT_hook: DNA binding domain with preference for A/T rich regions CC: Coiled Coil
|
Gene Ontology:
KEGG - Enzyme ID(s): KEGG - Orthology:
K04344
|
Nomenclature / Alternative Names:
EA2; Episodic ataxia type 2; CAV2.1; FHM; MHP; APCA; HPCA; MHP1; SCA6; CACNL1A4; CACH4; CACN3; Brain calcium channel 1; Voltage dependent P/Q type calcium channel alpha 1A subunit; Brain calcium channel I; Calcium channel, alpha 1A subunit isoform 1; Calcium channel, alpha 1A subunit isoform 2
|
Approved Symbol:
| (De-) Phosphorylations:
Phosphorylation Targets:
Total phosphorylation targets: 0 |
Human phosphorylation targets: 0; | Predicted platelet targets: 0 |
| Protein Characteristics:
| Associated Drugs (DrugBank Accession):
Bepridil(db); Loperamide(db); Pregabalin(db); Verapamil(db)
Associated Genetic Diseases:
Episodic ataxia, type 2(Pd); Episodic ataxia, type 2, and epilepsy(Pd); Migraine, familial hemiplegic 1, with progressive cerebellar ataxia(Pd); Migraine, familial hemiplegic, 1(Pd); Spinocerebellar ataxia 6(Pd)
| Predicted Transmembrane Domains:
03004_4(17) 03004_3(17) 03004_2(17) 03004_1(17)
|
| Additional Identifiers:
HPRD: | 03004 | | Entrez Gene ID: | 773 | | OMIM ID: | 601011 | | Swissprot Accession: | O00555; Q9NS88; | | |
|